Addex Therapeutics Aktie

Kaufen

Verkaufen

Aktien-Sparplan anlegen Aktien-Sparplan anlegen

0,0530 EUR -0,0036 EUR -6,36 %

22:42:48

L&S

0,0560 CHF +0,0020 CHF +3,70 %

17:31:31

SWX

Addex Therapeutics jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)

Jetzt loslegen

Direkt handeln

Bei einem anderen Broker handeln

Marktkap.8,71 Mio. EUR

KGV0,80Div. Rendite0,00%

WKNA0MSH6

ISINCH0029850754

SymbolADDXF

Addex Therapeutics Aktien News

Sortieren:Datum Meistgelesen

20.10.23GlobeNewswireAddex Completes ADS Ratio Change

06.10.23GlobeNewswireAddex Announces Plan to Implement ADS Ratio Change

20.09.23GlobeNewswireAddex mGlu2 NAM Cognition Program Receives €4 Million Grant

06.09.23GlobeNewswireAddex Announces Participation in the H.C. Wainwright 25th Annual Global Investment Conference

05.09.23GlobeNewswireAddex ADX71149 Phase 2 Epilepsy Study Expected to Readout Data in Q2 2024

04.09.23GlobeNewswireAddex’s Dipraglurant Development in Post-Stroke Recovery Supported by Data Published in Brain

10.08.23GlobeNewswireAddex Reports 2023 Half Year and Second Quarter Financial Results and Provides Corporate Update

04.08.23GlobeNewswireAddex Therapeutics to Release Half-Year 2023 Financial Results and Host Conference Call on August 10, 2023

03.08.23GlobeNewswireAddex GABAB Positive Allosteric Modulator Program to Receive Additional CHF2.7 Million from Indivior in Extended Substance Use Disorder Research Collaboration

24.07.23GlobeNewswireAddex mGlu2PAM Demonstrates Potential in Substance Use Disorder

15.06.23GlobeNewswireAddex Increases Issued Share Capital to Create Treasury Shares

01.06.23GlobeNewswireAddex Shareholders Approve All Resolutions at Annual General Meeting

18.05.23GlobeNewswireAddex Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

11.05.23GlobeNewswireAddex Reports Q1 2023 Financial Results and Provides Corporate Update

10.05.23GlobeNewswireAddex Announces ADX71149 Phase 2 Epilepsy Clinical Study’s Independent Interim Review Committee Recommends Continuing Study

05.05.23GlobeNewswireAddex Convenes Annual General Meeting 2023

04.05.23GlobeNewswireAddex Therapeutics to Release Q1 2023 Financial Results and Host Conference Call on May 11, 2023

05.04.23GlobeNewswireAddex Completes $5.0 Million Equity Financing

04.04.23GlobeNewswireAddex Publishes Dipraglurant Data Showing In Vivo Efficacy on Motor and Non-Motor Symptoms of Parkinson’s Disease

03.04.23GlobeNewswireAddex Raises $5.0 Million in Equity Financing

30.03.23GlobeNewswireAddex Reports Full Year 2022 Financial Results and Provides Corporate Update

28.03.23GlobeNewswireAddex Therapeutics to Release Full-Year 2022 Financial Results and Host Conference Call on March 30, 2023

16.03.23GlobeNewswireAddex Announces Upcoming Conferences it will participate for H1 2023

09.02.23GlobeNewswireAddex Regains Nasdaq Listing Compliance

Addex Therapeutics News

Addex Therapeutics News: auf dieser Seite finden Sie alle Addex Therapeutics News und Nachrichten zur Addex Therapeutics Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Addex Therapeutics News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Addex Therapeutics News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.